EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report

Elham Ramezanzade, Reyhane Ghanbari, Tina Yazdanipour

Nephro-Urology Monthly · 01.06.2022 · 14 (3)

DOI: 10.5812/numonthly-127124 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephro-Urology Monthly, online erschienen am 01.06.2022. Verfasst von Elham Ramezanzade und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a group of multisystemic autoimmune diseases that can involve organs such as kidneys and respiratory tracts. Since the initiation of COVID-19 vaccines, there have been few cases of antineutrophil cytoplasmic antibody (ANCA) glomerulonephritis development after receiving vaccine doses. Case Presentation: This report describes a 15-year-old man who has developed ANCA-associated glomerulonephritis (AAGN) after receiving the second dose of BBIBP-CorV (Sinopharm) COVID-19 vaccine.

Conclusions

Development of AAGN after both natural SARS-CoV-2 infection and following other vaccinations raises the question of the possible causality between the two. Considering the widespread use of COVID-19 vaccines, it is highly important to investigate their possible side effects.

Zitieren

APA

Ramezanzade, E., Ghanbari, R., & Yazdanipour, T. (2022). Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report. Nephro-Urology Monthly, 14(3). https://doi.org/10.5812/numonthly-127124

Vancouver

Ramezanzade E, Ghanbari R, Yazdanipour T. Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report. Nephro-Urology Monthly. 2022;14(3). doi:10.5812/numonthly-127124

BibTeX
@article{Ramezanzade2022,
  author = {Ramezanzade, Elham and Ghanbari, Reyhane and Yazdanipour, Tina},
  title = {Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report},
  journal = {Nephro-Urology Monthly},
  year = {2022},
  volume = {14},
  number = {3},
  doi = {10.5812/numonthly-127124}
}
Kostenlos starten →